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ABSTRACT
Objectives: While bidirectional relationships exist
between body weight and physical activity, direction of
causality remains uncertain and previous studies have
been limited by self-reported activity or weight and
small sample size. We investigated the prospective
relationships between weight and physical activity.
Design: Observational analysis of data from the
Nateglinide And Valsartan in Impaired Glucose
Tolerance Outcomes Research (NAVIGATOR) study, a
double-blinded randomised clinical trial of nateglinide
and valsartan, respectively.
Setting: Multinational study of 9306 participants.
Participants: Participants with biochemically
confirmed impaired glucose tolerance had annual
measurements of both weight and step count using
research grade pedometers, worn for 7 days
consecutively. Along with randomisation to valsartan or
placebo plus nateglinide or placebo, participants took
part in a lifestyle modification programme.
Outcome measures: Longitudinal regression using
weight as response value and physical activity as
predictor value was conducted, adjusted for baseline
covariates. Analysis was then repeated with physical
activity as response value and weight as predictor
value. Only participants with a response value
preceded by at least three annual response values were
included.
Results: Adequate data were available for 2811 (30%)
of NAVIGATOR participants. Previous weight (χ2=16.8;
p<0.0001), but not change in weight (χ2=0.1; p=0.71)
was inversely associated with subsequent step count,
indicating lower subsequent levels of physical activity
in heavier individuals. Change in step count (χ2=5.9;
p=0.02) but not previous step count (χ2=0.9; p=0.34)
was inversely associated with subsequent weight.
However, in the context of trajectories already
established for weight (χ2 for previous weight
measurements 747.3; p<0.0001) and physical activity
(χ2 for previous step count 432.6; p<0.0001), these
effects were of limited clinical importance.
Conclusions: While a prospective bidirectional
relationship was observed between weight and physical
activity, the magnitude of any effect was very small in
the context of natural trajectories already established
for these variables.
Trial registration number: NCT00097786.
The prevalence of obesity is rising in
most countries which reﬂects a chronic
Strengths and limitations of this study
▪ Bidirectional relationships have been observed
between body weight and physical activity in epi-
demiological studies, but previous studies have
been limited by small participant numbers, by
measurement of physical activity at only two
time points usually many years apart, and by the
lack of objective measures of physical activity.
We addressed this question in an analysis of
2811 Nateglinide And Valsartan in Impaired
Glucose Tolerance Outcomes Research
(NAVIGATOR) trial participants who underwent
annual objective measures of both weight and
physical activity.
▪ Participants were very well phenotyped at base-
line and all had biochemically confirmed
impaired glucose tolerance, a condition which
carries a very high risk of progression to type 2
diabetes and which therefore represents a clinic-
ally relevant group to study.
▪ This was an observational analysis and therefore
not able to provide information on causal rela-
tionships and, due to the moderate effect sizes
observed, it is possible for unmeasured con-
founding to explain the weak observed
associations.
▪ Regardless, our results suggest that only a weak
prospective relationship of limited clinical
importance exists between weight and physical
activity when considered in the context of natural
trajectories already established for each.
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imbalance between energy intake and energy expend-
iture.1 Some studies have suggested that a decline in
physical activity has contributed to this trend,2 while
others have suggested that there has been no obvious
trend of declining physical activity in recent decades.3 In
cross-sectional analyses, there are clear associations
between physical activity level and adiposity, but such
analyses do not allow conclusions about the direction of
causality to be drawn. This association could potentially
be driven by obesity leading to inactivity, inactivity
leading to obesity or a combination of both.
Previous studies have explored the associations both
between weight and subsequent physical activity, and
between physical activity and subsequent weight, to
investigate the strength of these relationships. Results
have been mixed with the majority of evidence suggest-
ing that baseline weight and increase in weight may be
important determinants of subsequent reductions in
physical activity (due to the greater difﬁculty of being
active at higher weight), but that activity or change in
activity has limited impact on subsequent weight.4–7
However, such studies have often been limited by small
participant numbers, by measurement of physical activity
at only two time points, usually many years apart, and by
the lack of objective measures of physical activity. This
ﬁnal point is important as inaccurate estimation of phys-
ical activity will diminish any apparent effect of physical
activity on an outcome measure.8 As weight is typically
measured with greater accuracy and precision than phys-
ical activity, studies where physical activity is measured by
self-report questionnaire have an inherent bias for the
detection of effects of weight or weight change on phys-
ical activity levels rather than associations in the opposite
direction, due to regression dilution bias effects.
To overcome the limitations of the existing evidence
base and provide insight into the direction of causality
for the relationship between weight and physical activity
at the population level, large-scale longitudinal analyses
are required with objective measurement of both physical
activity and weight at multiple time points. The
Nateglinide And Valsartan in Impaired Glucose
Tolerance Outcomes Research (NAVIGATOR) study was
a clinical trial conducted in participants with impaired
glucose tolerance (IGT). Given its inclusion of a large
number of participants with repeated objective measure-
ment of both weight and physical activity, we analysed the
NAVIGATOR data set to further investigate the prospect-
ive relationships between weight and physical activity.
PARTICIPANTS AND METHODS
NAVIGATOR (ClinicalTrials.gov number, NCT00097786)
was a multinational, double-blinded randomised clinical
trial with 2×2 factorial design which assessed the ability
of nateglinide and valsartan to respectively reduce major
cardiovascular events and new-onset diabetes in 9306
participants with IGT. Details of the trial were published
previously.9–11
Participants
On the basis of general criteria including age and
history of cardiovascular disease, possible research parti-
cipants attended screening clinics to assess their poten-
tial recruitment. Individuals with IGT were eligible if
they had one or more cardiovascular risk factor and
were aged ≥55 years or if they had established cardiovas-
cular disease and were aged ≥50 years. Detailed inclu-
sion and exclusion criteria are provided in previous
publications.9–11 Participants underwent a 75 g oral
glucose tolerance test and IGT was deﬁned as a 2 h post-
challenge glucose value of 7.8–11.0 mmol/L (with
fasting plasma glucose 5.3–6.9 mmol/L). Inclusion of a
participant in this analysis required the contribution of a
minimum set of data, as detailed below in the Statistical
analysis section. All NAVIGATOR participants provided
written informed consent.
Lifestyle modification
Participants took part in a lifestyle modiﬁcation pro-
gramme, starting at the baseline visit, based on the prin-
ciples of the Diabetes Prevention Programme12 and the
Finnish Diabetes Prevention Study.13 This was designed
with the aims of achieving and maintaining 5% weight
loss, reducing saturated and total fat intake, and increas-
ing levels of physical activity. Physical activity advice was
consistent with American Diabetes Association guidance,
namely to achieve at least 150 min of moderate intensity
activity each week. Participants were not given a speciﬁc
target for daily step count. Study personnel administered
the programme and provided materials to participants at
clinic visits within the ﬁrst year (at 0.5, 1, 3, 6 and
12 months). Subsequent reinforcement of the pro-
gramme was pursued through telephone contact.
Weight
Body weight was measured to the nearest 0.1 kg in
indoor clothing but without shoes at each visit (con-
ducted at 0.5, 1, 3 and 6 months, then every 6 months)
using the same scale. Annual weight data were used for
this analysis.
Step count
Ambulatory activity was measured objectively with research
grade pedometers (Accusplit, San Jose, California, USA)
which assess purposeful steps taken. Pedometers were dis-
patched to all NAVIGATOR study centres and were sup-
plied to a subset of participants based on practical
considerations. Two weeks after the baseline visit, partici-
pants were ﬁtted with a pedometer and instructed to wear
it during waking hours for seven consecutive days. They
were also provided with a log book to document their
daily step count. Ambulatory activity levels were reassessed
using the same criteria at yearly intervals. At each year, the
pedometer activity level was summarised as the average
over 7 days. Along with measure of habitual ambulatory
activity, daily step counts also provide a reasonable
measure of total physical activity levels.14
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Statistical analysis
We undertook a longitudinal regression to evaluate ped-
ometer steps as a predictor of future weight and subse-
quently reversing the relationship to evaluate weight as a
predictor of future pedometer steps. Thus, the response
variable, Y, was initially weight with independent vari-
able, X, being pedometer steps. Then, this was reversed.
Yi;t ¼ b0 þ b1  Yi;t1 þ b2  Yi;t2 þ b3  Yi;t3 þ b4
 DXi;ðt2Þ!ðt1Þ þ b5  Xi;t2 þ bp  Ci
where Yi,t is the the log-transformed response variable
for individual i at time t, similarly deﬁned for prior
times t−1 (minus 1 year), t−2 (minus 2 years) and t−3
(minus 3 years). Log transformation was necessary to
achieve normality for the response, for both weight and
pedometer steps. We let DXi;ðt2Þ!ðt1Þ be the change in
the predictor variable from time t−2 to t−1, Xi;t2 is the
predictor level at time t−2, and Ci index baseline covari-
ates for the ith individual. Thus, the estimate of
β4 describes the association between changes in X (eg,
pedometer counts) on subsequent values of the
response Y (eg, weight), among people with a common
history. β4 and β5 together describe the relationship
between the history of X and subsequent Y after
accounting for the prior history of Y.
Given the inclusion of lagged values of response as inde-
pendent variables, the model could only be ﬁt to response
data starting at year 3. Only participants with response
values at time t, preceded by three annual response values,
at t−1, t−2, t−3 and a predictor value at t−1 and t−2 were
included in the analysis. More lags were not considered
because the number of patients contributing consecutive
data points became small. However, responses at years 4, 5
and 6 were analysed as repeated measures, wherever avail-
able. Generalised estimating equations with a robust SE
estimate were used to account for correlation from using
multiple responses within individuals.
The analysis was conducted before and after adjust-
ment for the following baseline characteristics: age, sex,
race, region, smoking status, waist circumference, systolic
blood pressure, pulse pressure, chronic obstructive pul-
monary disease, atrial ﬁbrillation/ﬂutter, low-density
lipoprotein and high-density lipoprotein cholesterol, pla-
telets, haemoglobin, log of albumin/creatinine ratio,
sodium, estimated glomerular ﬁltration rate, ECG abnor-
malities, congestive heart failure, cerebrovascular
disease, coronary heart disease, pulmonary disease, per-
ipheral artery disease and family history of diabetes.
Missing adjustment covariates were imputed; less than
3% of data were missing for baseline adjustment
covariates.
Funding
NAVIGATOR was designed by an academic executive
committee in collaboration with the sponsor, Novartis
Pharmaceuticals, who funded the study. Statistical
analyses were performed independently by statisticians
at the Duke Clinical Research Institute (Durham, North
Carolina, USA). The authors of this manuscript are
solely responsible for the design and conduct of this
study, all statistical analyses, and the drafting and editing
of the paper and its ﬁnal contents.
RESULTS
From the total NAVIGATOR population of 9306 indivi-
duals, 2811 had complete weight and physical activity
data over the required time points. The baseline
characteristics of those included in and excluded from
the analysis are provided in table 1. Average age was
63 years, 50% were female and median weight at base-
line was 80 kg. All models included 7318 data points
from the 2811 participants; 755 participants contributed
one data point, 546 contributed two data points, 569
contributed three data points and 941 contributed four
data points. The median baseline step count was 6592
(IQR 4311–9334) steps per day. From baseline to the last
recorded measurement in these 2811 individuals, step
count fell by a median of 372 (IQR −2520 to 1651) steps
per day while weight remained unchanged (median
0.0 kg (IQR −3.5 to 3.2 kg)).
Association of previous weight and recent change in
weight with subsequent step count
Table 2 details the association of previous weight and
recent change in weight with physical activity, after
Table 1 Baseline characteristics of NAVIGATOR
participants
Variable
Included
in analysis
(n=2811)
Excluded
from analysis
(n=6495)
Age 63 (58–68) 63 (58–69)
Gender (female, %) 1418 (50.4) 3293 (50.7)
Race
Caucasian 2243 (79.8) 5491 (84.5)
Asian 308 (11.0) 305 (4.7)
African–American 29 (1.0) 207 (3.2)
Other 231 (8.2) 492 (7.6)
Weight (kg) 80 (70–91) 83 (72–95)
Systolic BP (mm Hg) 140 (129–150) 139 (128–150)
Coronary heart
disease
835 (29.7) 1791 (27.6)
Cerebrovascular
disease
259 (9.2) 477 (7.3)
Congestive heart
failure
124 (4.4) 207 (3.2)
Peripheral arterial
disease
70 (2.5) 239 (3.7)
Chronic obstructive
pulmonary disease
114 (4.1) 337 (5.2)
Values are median (IQR) or n (%).
BP, blood pressure; NAVIGATOR, Nateglinide And Valsartan in
Impaired Glucose Tolerance Outcomes Research.
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adjusting for the previous trajectory of physical activity.
Previous weight was inversely associated with subsequent
step count, indicating lower subsequent levels of physical
activity in heavier individuals. When expressed in abso-
lute terms, however, every 1 kg higher weight was asso-
ciated with only 0.21% fewer steps in the subsequent
year of measurement in otherwise similar individuals
(table 2). For example, in two otherwise similar indivi-
duals with a daily step count of approximately 10 000/
day, a 10 kg heavier person would walk only 220 fewer
steps per day, in the subsequent year. This limited clin-
ical impact was reﬂected by the ﬁnding that the adjusted
R2 for prior step count and weight data was only margin-
ally different from the adjusted R2 for only prior step
count (0.5882 vs 0.5895) in its association with subse-
quent step count, that is, weight data only explained
0.13% of the variance in subsequent step count. Change
in weight was not associated with subsequent step count
in the model (p=0.71). The previous trajectory of phys-
ical activity was strongly associated with subsequent phys-
ical activity levels as expected.
Association of previous step count and recent change in
step count with weight
Table 3 details the association of previous step count
and recent change in step count with subsequent
weight, after adjusting for the previous trajectory of
weight. Step count at a previous visit was not associated
with subsequent weight (p=0.34), but change in step
count was inversely associated with subsequent weight in
the model. When expressed in absolute terms, however,
every additional 2000 steps were associated with only
0.08% lower weight at the subsequent study visit in
otherwise similar individuals (table 3). Among two
otherwise similar individuals weighing 80 kg, a 2000
increase in daily step count was associated with only 60 g
lower weight at the subsequent visit. This limited clinical
impact was reﬂected by the ﬁnding that the adjusted
R2 for prior weight and step count data was similar to
the adjusted R2 for only prior weight (0.9651 vs 0.9652)
in its association with subsequent weight, that is, step
count data only explained 0.01% of the variance in
subsequent weight. The previous trajectory of weight was
strongly associated with subsequent weight as expected.
DISCUSSION
In 2811 NAVIGATOR participants with IGT who under-
went regular objective measurements of weight and
physical activity, the following ﬁndings relating to the
bidirectional nature of the prospective associations
between these variables emerged. Previous weight, but
not recent change in weight, was inversely associated
with subsequent levels of physical activity. Recent change
in physical activity, but not previous physical activity, was
inversely associated with subsequent weight. However,
the relative contributions of weight to subsequent phys-
ical activity and of physical activity to subsequent weight,
while statistically signiﬁcant, were of somewhat limited
clinical importance. Previous physical activity was very
strongly associated with subsequent activity and, similarly,
previous weight with subsequent weight but addition of
weight and physical activity data, respectively, had negli-
gible effect on prediction of the other.
Previous studies have investigated the prospective rela-
tionships between weight and physical activity with a
variety of approaches and also suggested that any link is
very modest. In an observational analysis of the
Womens’ Health Study (n=34 079), participants gained
an average of 2.6 kg over 13 years.15 Those who were
least active at baseline gained only 0.12 kg more weight
than the most active participants over 3 years.
Importantly, both weight and physical activity were self-
reported. In a study of 288 498 participants in the
European Prospective Investigation into Cancer and
Nutrition which included baseline self-reporting of activ-
ity (inactive, moderately inactive, moderately active and
active categories) plus baseline and follow-up objective
measurement of weight and waist circumference, phys-
ical activity had no relationship with subsequent
weight.16 A single category increment in activity only led
to 0.4–0.5 mm/year smaller waist circumference. The
association between baseline weight and future activity
was not investigated in these studies.
Table 2 Associations of previous step count, previous weight and recent change in weight with subsequent step count
(adjusted model)
Parameter Estimate SE χ2 p Value Joint effects
Log step count (t−3) 0.1175 0.0169 41.9 <0.0001 432.6
Log step count (t−2) 0.2263 0.0194 98.2 <0.0001 (p<0.0001)
Log step count (t−1) 0.5045 0.0197 320.6 <0.0001
Weight (t−2) −0.0021 0.0005 16.8 <0.0001 17.8
Change in weight (t−1) −0.0028 0.0018 0.1 0.71 (p=0.0001)
Adjusted for step count values from last three annual visits (t−1, t−2, t−3) and baseline covariates (age, sex, race, region, smoking status,
waist circumference, systolic blood pressure, pulse pressure, chronic obstructive pulmonary disease, atrial fibrillation/flutter, low-density
lipoprotein and high-density lipoprotein cholesterol, platelets, haemoglobin, log of albumin/creatinine ratio, sodium, estimated glomerular
filtration rate, ECG abnormalities, congestive heart failure, cerebrovascular disease, coronary heart disease, pulmonary disease, peripheral
artery disease and family history of diabetes).
Weight expressed per kg and step count per 2000 steps.
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However, the majority of studies have suggested that
previous weight is a determinant of subsequent physical
activity. In an observational Danish study of 6279 adults
who attended three study visits over 10 years, the investi-
gators found no difference in the risk of developing
obesity according to levels of physical activity at base-
line.4 In contrast, those with high body mass index
(BMI) were at elevated risk of becoming inactive com-
pared with those with median BMI. A similar study from
the same research group of 1143 obese adults and 1278
non-obese controls yielded similar results.5 While weight
was objectively measured, categories of physical activity
were again recorded by self-report questionnaire. The
Medical Research Council Ely Study followed up 393
middle-aged adults for 5.6 years and analysed data for
objectively measured weight and activity levels (derived
from heart rate monitor data), recorded at two visits, in
a further observational study.6 Here, baseline sedentary
time did not predict any subsequent measures of adipos-
ity but most baseline measures of adiposity were posi-
tively associated with subsequent sedentary time. In the
University of North Carolina Alumni Heart Study of
4595 men and women, studied from age 41 to 54, BMI
was again positively associated with the risk of becoming
sedentary.7 Sedentary lifestyle did not predict change in
subsequent BMI, a ﬁnding replicated in other studies.17
However, a positive association with adiposity did
emerge from their statistical model when change in
physical activity was added as a variable. Two interesting
small intervention studies have further supported the
hypothesis that weight change is a determinant of subse-
quent physical activity. In Levine et al’s18 study of lean
(n=10) and obese (n=12) participants who were overfed
by 1,000 kcal/day for 8 weeks and who gained 3.6 kg in
weight from this experimentally induced overfeeding,
both groups walked approximately 1.5 miles/day less
(objectively measured) after the intervention. Bonomi
et al used an alternative approach by exposing 66 over-
weight or obese participants to a 67% energy restricted
diet for 6 weeks. Participants lost weight and this was
associated with a subsequent increase in physical activity
recorded with triaxial accelerometers.19 By contrast, a
study in which 25 adults were overfed (140% of energy
needs) for 8 weeks led to increases in activity and energy
expended in physical activity.20 However, these studies
were conducted over relatively short periods of time and
therefore assess acute changes in behaviour, rather than
the longer term effects investigated in the present study.
The current results largely support these earlier ﬁnd-
ings and add further information regarding the magni-
tude of the associations between weight and activity.
While the ﬁndings from NAVIGATOR generally support
the hypothesis that there is a bidirectional prospective
relationship between weight and physical activity which
provides important and novel insights into the nature of
these associations, an important conclusion was that the
magnitude of these associations was of limited clinical
importance, in the context of the changes observed in
this observational analysis. Therefore, in clinical terms, it
appears important to both directly target increasing
activity, primarily for its associated beneﬁts independent
of weight loss (eg, improved insulin sensitivity, blood
pressure, lipoprotein metabolism, vascular function21)—
as weight loss may have a limited effect on habitual
activity—and to directly target weight loss, through
dietary restriction, rather than via increased physical
activity, as increased natural variation in physical activity
may have limited effect on weight. Although life-long
activity may contribute to weight and vice versa, natural
variation in these parameters, after diagnosis with IGT,
appears too small to signal a new trajectory. Instead it is
dwarfed by the trajectory that has already been
established.
Strengths of this analysis of the NAVIGATOR cohort
include the large number of participants from whom
objective measures of both weight and physical activity
were available. Data from multiple time points also
allowed us to study the potential relationships between
weight and activity beyond the trajectories already estab-
lished for these variables within individuals. Participants
were well phenotyped at baseline and, importantly, all
had IGT, a condition associated with very high risk of
progression to type 2 diabetes and therefore a clinically
relevant group in which to study the relationship
Table 3 Associations of previous weight, previous step count and recent change in step count with subsequent weight
(adjusted model)
Parameter Estimate SE χ2 p Value Joint effects
Log (weight (t−3)) 0.0885 0.0123 46.8 <0.0001 747.3
Log (weight (t−2)) 0.1339 0.0183 43.0 <0.0001 (p<0.0001)
Log (weight (t−1)) 0.7638 0.0191 484.9 <0.0001
Step count (t−2) −0.0003 0.0003 0.9 0.34 5.9
Change in step count (t−1) −0.0008 0.0003 5.9 0.02 (p=0.05)
Adjusted for weight values from last three annual visits (t−1, t−2, t−3) and baseline covariates (age, sex, race, region, smoking status, waist
circumference, systolic blood pressure, pulse pressure, chronic obstructive pulmonary disease, atrial fibrillation/flutter, low-density lipoprotein
and high-density lipoprotein cholesterol, platelets, haemoglobin, log of albumin/creatinine ratio, sodium, estimated glomerular filtration rate,
ECG abnormalities, congestive heart failure, cerebrovascular disease, coronary heart disease, pulmonary disease, peripheral artery disease
and family history of diabetes).
Weight expressed per kg and step count per 2000 steps.
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between activity and weight. Weaknesses of our study
include that this was an observational analysis and there-
fore not able to provide information on causal relation-
ships. Given the non-randomised nature of this study
and moderate effect sizes, it is possible for unmeasured
confounding to explain the associations. However, this is
unlikely to substantially alter our conclusion that the
associations do not suggest a strong relationship. In add-
ition, our analysis does not evaluate life-long causal rela-
tionships, but only the most recent variations in the
predictor, after adjusting for the response trajectory that
has already been established. In observational data, this
is as close as can be achieved for blocking reverse caus-
ation. However, among people with a similar response
trajectory, there may be relatively little variation in pre-
dictor values. Therefore, our conclusions do not gener-
alise to an intervention that could induce much greater
differences between individuals than are seen in natural
behaviour. Participants were followed for variable
periods of time and therefore contributed variable
numbers of data points with the result that data from
only 30% of NAVIGATOR participants were considered
adequate for our analytical approach. We used step
count as a measure of physical activity which does not
provide information on intensity. This may have limited
our ability to detect any associations between
moderate-to-vigorous physical activity and body weight.
While we analysed our data according to the principles
of Granger causation, other approaches such as latent
growth curve modelling have been applied to such longi-
tudinal data.22 As the design of the analysis precluded a
comparison group, we were unable to take into consider-
ation the natural trajectories of changes in activity and
weight in such individuals. Finally, our participants were
relatively old with IGT and at high risk of cardiovascular
disease, and thus our ﬁndings may not be generalisable
to all groups.
In summary, while we observed inverse associations
between previous weight and subsequent physical activity
plus recent change in physical activity and subsequent
weight, in keeping with a bidirectional relationship, the
magnitude of these associations was of limited clinical
signiﬁcance.
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